Search
for

    Sort by

    Research 121–150 of 122

    1. Antibody Drug Conjugates Oncology Times · 2020
    2. ZALCITABINE 2004
    3. Tufted hair folliculitis in a woman treated with trastuzumab Targeted Oncology · 2010 · 28 citations
    4. Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect Journal of clinical medicine · 2019 · 15 citations
    5. Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis Frontiers in Pharmacology · 2023 · 13 citations
    6. Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab Breast Cancer Basic and Clinical Research · 2018 · 12 citations
    7. Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Drug safety · 2023 · 3 citations
    8. Alopecia/hair loss in all patients treated with trastuzumab and paclitaxel: myth or reality? Annals of Oncology · 2017 · 1 citations
    9. TRASTUZUMAB 2004
    10. Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer ESMO Open · 2022 · 60 citations
    11. Permanent chemotherapy-induced alopecia: Case report and review of the literature Journal of The American Academy of Dermatology · 2010 · 67 citations
    12. Multiple drugs Reactions Weekly · 2017
    13. Antibody-drug conjugate induced hair loss responds to minoxidil: A case report SKIN The Journal of Cutaneous Medicine · 2025
    14. Abstract P1-12-19: A case report of successful hair preservation using scalp cooling with doxorubicin and cyclophosphamide during pregnancy Clinical Cancer Research · 2025
    15. DRUG NEWS ​​​​​​​​​​​​​​Nursing2023 · 2013
    16. Clinical and histological study of permanent alopecia after bone marrow transplantation Anais Brasileiros de Dermatologia · 2015 · 23 citations
    17. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer Cureus · 2018 · 3 citations
    18. Exuberant tufted folliculitis 2019 · 2 citations
    19. Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases Annals of Oncology · 2012 · 2 citations
    20. Is dehydroepiandrosterone a hormone? Journal of Endocrinology · 2005 · 403 citations
    21. Targeting the Wnt pathways for therapies Molecular and cellular therapies · 2014 · 112 citations
    22. Acne and Systemic Disease Medical Clinics of North America · 2009 · 76 citations
    23. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients Annals of Oncology · 2012 · 68 citations
    24. Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations Expert review of dermatology · 2011 · 62 citations
    25. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study ˜The œoncologist · 2018 · 59 citations
    26. Hair disorders in patients with cancer Journal of The American Academy of Dermatology · 2018 · 53 citations
    27. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    28. The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches Annual Review of Cell and Developmental Biology · 2016 · 42 citations
    29. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications IntechOpen eBooks · 2020 · 39 citations
    30. Androgen receptor: A promising therapeutic target in breast cancer Critical Reviews in Clinical Laboratory Sciences · 2019 · 21 citations